Research programme: non-opioid therapeutics - PixarBio

Drug Profile

Research programme: non-opioid therapeutics - PixarBio

Alternative Names: NeuroRelease; NeuroRelease SCI; NR-SCI - PixarBio; NR-TN - PixarBio

Latest Information Update: 10 Jan 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator PixarBio Corporation
  • Class Non-opioid analgesics
  • Mechanism of Action Undefined mechanism
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Preclinical Pain
  • Research Epilepsy; Parkinson's disease; Spinal cord injuries; Trigeminal neuralgia

Most Recent Events

  • 05 Jan 2017 Preclinical trials in Pain in USA (Parenteral)
  • 24 Jun 2016 Early research in Epilepsy in USA (Parenteral)
  • 24 Jun 2016 Early research in Parkinson's disease in USA (Parenteral)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top